What is the TTN gene?

The TTN gene provides instructions for making titin, a protein that helps heart and skeletal muscle cells keep their structure and stretch as they work. Certain disease-causing TTN variants can affect the heart, the muscles used for movement, or both. The effect depends on the specific variant.

How can TTN affect the heart?

TTN is an important genetic cause of dilated cardiomyopathy (DCM), in which the heart becomes enlarged and pumps less effectively. DCM can also be associated with abnormal heart rhythms. A heart evaluation is needed to determine whether a person with a TTN variant has developed cardiomyopathy.

What is a TTN truncating variant?

A truncating variant is a genetic change that can cause the body to make a shortened version of the titin protein. Some TTN truncating variants are linked to DCM, but a truncating result does not automatically mean the variant causes heart disease. Its location and other evidence about the specific variant matters. Ask a genetic counselor or cardiomyopathy specialist to review the exact variant found on your report.

Does a TTN variant mean I will develop cardiomyopathy?

Not necessarily. Some people with a disease-causing variant have no detectable heart changes when they are first tested, and relatives with the same variant can be affected differently. A variant of uncertain significance (VUS) has not been confirmed to cause disease. Your care team can interpret your result alongside your heart tests and family history.

What symptoms should I tell my care team about?

Tell your care team about shortness of breath, unusual fatigue, swelling in your legs or feet, a fluttering or pounding heartbeat, dizziness, fainting, or a change in how much activity you can manage. Unexplained fainting needs prompt medical evaluation. Keep recommended checkups even if you feel well.

Can a TTN variant affect muscles outside the heart?

Yes, some TTN variants are associated with weakness in the muscles used for movement. Other variants primarily affect the heart. Heart symptoms do not mean you will develop muscle weakness. Tell your care team about new or progressive weakness so they can decide whether a muscle evaluation would help.

Does TTN matter if I am pregnant or planning a pregnancy?

Some TTN truncating variants have been found in people with peripartum cardiomyopathy, a form of heart weakness that develops near the end of pregnancy or after delivery. This does not mean that everyone with a TTN variant will develop it. If you are pregnant or planning a pregnancy, discuss your genetic result and heart history with your cardiology and pregnancy care teams so they can plan appropriate evaluation and follow-up.

Should my family members have genetic testing?

If your TTN variant is classified as pathogenic or likely pathogenic for cardiomyopathy, a genetic counselor can help identify relatives who may benefit from testing for that specific variant and from heart screening. TTN-related DCM often follows an autosomal dominant pattern: each child of someone with the disease-causing variant has a 50% chance of inheriting it. Inheriting it does not predict exactly how their health will be affected.

What follow-up care might I need?

Your specialist may recommend an electrocardiogram (ECG), an echocardiogram, heart rhythm monitoring, or, in some circumstances, a cardiac MRI. These tests can check heart structure, pumping function, and rhythm. Your follow-up plan will depend on your variant, symptoms, family history, and test results.

Is there treatment for TTN cardiomyopathy?

Treatment depends on your heart findings, rather than the gene result alone. If you have DCM, your care team may discuss medications to support heart function and, for some people, a device to treat dangerous rhythms. Regular assessment helps your specialist decide whether treatment is needed or should change.

Where can I connect with others affected by TTN?

Sign up for GCAC’s TTN patient community for updates, resources, and ways to connect with others who have the TTN gene.